You are not currently logged in.
Access JSTOR through your library or other institution:
Gatifloxacin-Associated Corrected QT Interval Prolongation, Torsades de Pointes, and Ventricular Fibrillation in Patients with Known Risk Factors
Joseph S. Bertino, Jr., Robert C. Owens, Jr., Timothy D. Carnes and Paul B. Iannini
Clinical Infectious Diseases
Vol. 34, No. 6 (Mar. 15, 2002), pp. 861-863
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4461981
Page Count: 3
You can always find the topics here!Topics: Torsades de Pointes, Dosage, Ventricular fibrillation, Predisposing factors, Congestive heart failure, Musical intervals, Fluoroquinolones, Disease risks, Medications, Infectious diseases
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Drugs not commonly considered to be cardioactive agents have been reported to cause prolongation of the corrected QT interval with resultant torsades de pointes or ventricular fibrillation. We report 4 cases of gatifloxacin-associated cardiac toxicity in patients with known risk factors for this adverse event.
Clinical Infectious Diseases © 2002 Oxford University Press